G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 124 filers reported holding G1 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $158,000 | -25.5% | 20,759 | 0.0% | 0.00% | – |
| Q4 2021 | $212,000 | -21.2% | 20,759 | +3.7% | 0.00% | -100.0% |
| Q3 2021 | $269,000 | -38.7% | 20,012 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $439,000 | +33.0% | 20,012 | +46.0% | 0.00% | 0.0% |
| Q1 2021 | $330,000 | +36.4% | 13,708 | +1.9% | 0.00% | – |
| Q4 2020 | $242,000 | +56.1% | 13,448 | 0.0% | 0.00% | – |
| Q3 2020 | $155,000 | -51.6% | 13,448 | +1.8% | 0.00% | -100.0% |
| Q2 2020 | $320,000 | +119.2% | 13,208 | 0.0% | 0.00% | – |
| Q1 2020 | $146,000 | -58.2% | 13,208 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $349,000 | +17.9% | 13,208 | +1.6% | 0.00% | 0.0% |
| Q3 2019 | $296,000 | -25.8% | 12,998 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $399,000 | -11.1% | 12,998 | +51.5% | 0.00% | 0.0% |
| Q3 2018 | $449,000 | +41.6% | 8,581 | +17.5% | 0.00% | 0.0% |
| Q2 2018 | $317,000 | – | 7,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
| DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
| XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
| Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
| ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |